Previously Published on diaTribe.org – Impressive results from a trial for an up-and-coming artificial pancreas showed that users spent an average of 2.6 more hours in range each day compared to non-users – all without counting carbs. Here’s what trial participants are saying about the new system, The iLet Bionic Pancreas. What is the iLet Bionic Pancreas?…
Previously Published on Medscape.com – The odds of a person with type 1 diabetes achieving target A1c levels and avoiding severe hypoglycemia increase with greater degrees of automation in the technology they’re using, new real-world data show. Most notably, the likelihood of experiencing a severe hypoglycemic episode in the prior year was more than double for…
A Canadian study has concluded a novel dual-hormone artificial pancreas system improves glucose control in patients with type 1 diabetes. Researchers from McGill University’s Faculty of Medicine compared the dual-hormone system with a rapid insulin-alone artificial pancreas. According to the findings the D-HAP increased the blood glucose time in range from 74% to 84%. The…
Dawn Belt Davis, MD, PhD talks about hopeful T1D breakthroughs coming in 2018. She’s the associate professor in the division of endocrinology, diabetes and metabolism at the University of Wisconsin School of Medicine. Davis speaks about exciting research in islet transplantation, 670g artificial pancreas system, insulin pumps and more. Lets hope that 2018 brings major advances in…
Just a reminder that the MiniMed 670G hybrid closed loop System will be available to the public in the spring of 2017. We will let you know when it becomes available or are any updates with the system so please check back here often. Minimed 670g system available spring 2017, FDA approved. The Minimed…
Medical device maker Medtronic has won Food and Drug Administration (FDA) approval for the MiniMed 670G device. The “hybrid closed loop system” monitors and adjusts glucose and insulin levels in patients with type 1 diabetes. The first artificial pancreas approved of its kind for treating diabetes will hit the market in spring of 2017. The…
The Artificial Pancreas is a smart idea and does show promise in controlling blood sugars for type 1 diabetics who are currently using insulin pumps. The system uses a modified iPhone connected to a glucose monitor and pumps that deliver the insulin and glucagon. It mimics the natural release of daily insulin and eliminates injections….